Home --- Hintergrund & medizinische Fachliteratur -- Immunantwort -- Our bodies are trying to fight the bug off ...

Posting to sci.med.diseases.lyme:

Subject: Cytokines, Flare Cycles and the Immune System

"Our bodies are trying to fight the bug off, but keep forgetting what the bug looks like."

As I pointed out in my previous message, I wanted to find a better interpretation of Joseph Burrascano's habit of using the existence of flare cycles as a guide for the antibiosis. He has so much information that I think his method is working.

Here's again the "entrance page" to my interpretation:

And here's again what Dr. Burrascano writes in http://www2.lymenet.org/domino/file.nsf/UID/guidelines#LYME DISEASE TREATMENT GUIDELINES

"....It has been observed that symptoms will flare in cycles every four weeks. It is thought that this represents the organism's cell cycle, with the growth phase occurring once per month. As antibiotics will only kill bacteria during their growth phase, therapy is designed to bracket at least one whole generation cycle. This is why the minimum treatment duration should be at least four weeks. If the antibiotics are working, over time these flares will lessen in severity and duration. The very occurrence of ongoing monthly cycles indicates that living organisms are still present and that antibiotics should be continued.

... Patients on I.V. therapy who have a strong reaction at the fourth week will need to continue parenteral antibiotics for several months, for when this monthly reaction finally lessens in severity, then oral or IM medications can be substituted. Indeed, it is just this observation that guides the clinician in determining the endpoint of I.V. treatment. In general, I.V. therapy is given until there is a clear positive response, then treatment is changed to IM or po until free of signs of active infection for 4 to 8 weeks.... "

Although we believe the results of his interpretation are very valuable

(in fact Jennifer Nields thinks that more and more of his ideas will become established knowledge in the scientific Lyme community)

and we've followed his advice with excellent success (http://www.lymenet.de/symptoms/cycles/statistics.htm#symptomlog), I didn't believe this interpretation. It just didn't make sense to me that

So I tried another interpretation leading to the same results. If you are happy with Burrascano's method, you might not need my alternative interpretation. It's hypothetical anyway.

The basics of the interpretation are:

Remark 1 concerning kill kinetics

I think, the Bb life cycles are probably statistically distributed over time. So, during one Bb generation time the cell wall antibiotic will see half of the population undergo cell division and thus have a chance to kill this half. One needs to continue attempting to kill half the remaining population over many generation times (Example: If you want to reduce a population of 1000 Bb down to 1 Bb, you need 10 generation times. This is what the in vitro kill kinetics experiments explore.

(-) Preac-Mursic V, Marget W, Busch U, Pleterski D, Rigler S, Hagl S, Kill Kinetics of Borrelia burgdorferi, Infection, 24: 9 - 16, 1996.

(-) Agger WA, Callister SM, Jobe DA, In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone", Antimicrob Agents Chemother 1992; Aug;36(8):1788-90.

Remark 2 concerning niches

To me their position seems not helpful for treatment, since so many of the DD's are illnesses that can only be treated symptomatically, i.e. not healed. Its value lies in the fact that it allows the scientist to define very cleanly the basis of his/her research, which is indispensable for the progress of research. As long as so much is still unknown, both "pools" seem to be beneficially complementary.


  • version: December 3, 1999
  • http://www.lymenet.de/symptoms/sci.med.diseases.lyme/23.2.99.htm
  • Send comments to Joachim Gruber.